Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT06291987
Title Ivosidenib and Ruxolitinib in Patients With Advanced Blood Cancers That Have IDH1 Gene MutationPhase MPNs (MPN)
Acronym MPN
Recruitment Not yet recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors University of Chicago
Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST